Standout Papers

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease... 2013 2026 2017 2021 414
  1. Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease (2013)
    J.‐F. Yale, George L. Bakris et al. Diabetes Obesity and Metabolism

Immediate Impact

1 from Science/Nature 93 standout
Sub-graph 1 of 20

Citing Papers

Diabetes mellitus—Progress and opportunities in the evolving epidemic
2024 Standout
Photo-neuro-immuno-endocrinology: How the ultraviolet radiation regulates the body, brain, and immune system
2024 Standout
2 intermediate papers

Works of Ewa Wajs being referenced

Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
2013 Standout
Melatonin affects proopiomelanocortin gene expression in the immune organs of the rat
1995

Author Peers

Author Last Decade Papers Cites
Ewa Wajs 805 478 313 352 45 1.4k
Valéria Lamounier‐Zepter 515 391 182 636 34 1.6k
Kensuke Toyama 438 262 131 447 56 1.7k
Andreas Meier 274 172 170 120 52 1.5k
Lawrence M. Fishman 820 438 51 338 55 1.7k
Mohammad Asghar 423 84 100 559 46 1.7k
Jacqueline Yee 861 468 180 348 22 1.2k
Osamu Hanyu 535 334 42 213 68 1.4k
Jie Qi 166 307 147 489 67 1.6k
Frank Niklasson 142 203 74 299 57 1.4k
A. Dejgaard 768 318 179 350 45 1.6k

All Works

Loading papers...

Rankless by CCL
2026